-
1
-
-
0028927607
-
The Fas death factor
-
Nagata S, Golstein P. The Fas death factor. Science 1995;267: 1449-56.
-
(1995)
Science
, vol.267
, pp. 1449-1456
-
-
Nagata, S.1
Golstein, P.2
-
2
-
-
0024596722
-
A cell-killing monoclonal antibody (anti-Fas) to cell surface antigen co-downregulated with the receptor of tumor necrosis factor
-
Yonehara S, Ishii A, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989;169:1747-56.
-
(1989)
J Exp Med
, vol.169
, pp. 1747-1756
-
-
Yonehara, S.1
Ishii, A.2
Yonehara, M.3
-
3
-
-
0026706261
-
Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor family: Sequence identity with the Fas antigen
-
Oehn A, Behrman I, Falk W, et al. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor family: sequence identity with the Fas antigen. J Biol Chem 1992;267:10709-15.
-
(1992)
J Biol Chem
, vol.267
, pp. 10709-10715
-
-
Oehn, A.1
Behrman, I.2
Falk, W.3
-
4
-
-
0025916387
-
The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
-
Itoh N, Yonehara S, Ishii A, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991;66:233-43.
-
(1991)
Cell
, vol.66
, pp. 233-243
-
-
Itoh, N.1
Yonehara, S.2
Ishii, A.3
-
5
-
-
0028485743
-
The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice
-
Singer GG, Abbas AK. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1994;1:365-71.
-
(1994)
Immunity
, vol.1
, pp. 365-371
-
-
Singer, G.G.1
Abbas, A.K.2
-
6
-
-
0028909197
-
Fas ligand mediates activation-induced cell death in human T lymphocytes
-
Alderson MR, Tough TW, Davis-Smith T, et al. Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 1995;181:71-7.
-
(1995)
J Exp Med
, vol.181
, pp. 71-77
-
-
Alderson, M.R.1
Tough, T.W.2
Davis-Smith, T.3
-
7
-
-
0028795758
-
Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)
-
Dhein J, Walczak H, Bäumler C, Debatin KM, Krammer PH. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 1995;373:438-41.
-
(1995)
Nature
, vol.373
, pp. 438-441
-
-
Dhein, J.1
Walczak, H.2
Bäumler, C.3
Debatin, K.M.4
Krammer, P.H.5
-
8
-
-
0028983657
-
Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas
-
Brunner T, Mogil RJ, LaFace D, et al. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995;373:441-4.
-
(1995)
Nature
, vol.373
, pp. 441-444
-
-
Brunner, T.1
Mogil, R.J.2
LaFace, D.3
-
9
-
-
0028893078
-
Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation
-
Ju ST, Panka DJ, Cui H, et al. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995;373:444-8.
-
(1995)
Nature
, vol.373
, pp. 444-448
-
-
Ju, S.T.1
Panka, D.J.2
Cui, H.3
-
10
-
-
0029025441
-
Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome
-
Fisher GH, Rosenberg FJ, Straus SE, et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995;81:935-46.
-
(1995)
Cell
, vol.81
, pp. 935-946
-
-
Fisher, G.H.1
Rosenberg, F.J.2
Straus, S.E.3
-
11
-
-
0028980902
-
Fas and Fas ligand: Lpr and gld mutations
-
Nagata S, Suda T. Fas and Fas ligand: lpr and gld mutations. Immunol Today 1995;16:39-43.
-
(1995)
Immunol Today
, vol.16
, pp. 39-43
-
-
Nagata, S.1
Suda, T.2
-
12
-
-
0028864778
-
A role for CD95 ligand in preventing graft rejection
-
Bellgrau D, Gold D, Selawry H, Moor J, Franzusoff A, Duke RC. A role for CD95 ligand in preventing graft rejection. Nature 1995; 377:630-2.
-
(1995)
Nature
, vol.377
, pp. 630-632
-
-
Bellgrau, D.1
Gold, D.2
Selawry, H.3
Moor, J.4
Franzusoff, A.5
Duke, R.C.6
-
13
-
-
0028879109
-
Fas ligand-induced apoptosis as a mechanism of immune privilege
-
Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995;270:1189-92.
-
(1995)
Science
, vol.270
, pp. 1189-1192
-
-
Griffith, T.S.1
Brunner, T.2
Fletcher, S.M.3
Green, D.R.4
Ferguson, T.A.5
-
14
-
-
10544232277
-
Melanoma cell expression of Fas (Apo-1/CD95) ligand: Implications for tumor immune escape
-
Hahne D, Rimoldi M, Schröter P, et al. Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape. Science 1996;274:1363-6.
-
(1996)
Science
, vol.274
, pp. 1363-1366
-
-
Hahne, D.1
Rimoldi, M.2
Schröter, P.3
-
15
-
-
16144363507
-
Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells: A mechanism of immune evasion?
-
Strand S, Hofmann WJ, Hug H, et al. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells: a mechanism of immune evasion? Nature Med 1996;2:1361-6.
-
(1996)
Nature Med
, vol.2
, pp. 1361-1366
-
-
Strand, S.1
Hofmann, W.J.2
Hug, H.3
-
16
-
-
0029808372
-
The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand
-
O'Connell BJ, O'Sullivan GC, Collins JK, Fergus S. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med 1996;184:1075-82.
-
(1996)
J Exp Med
, vol.184
, pp. 1075-1082
-
-
O'Connell, B.J.1
O'Sullivan, G.C.2
Collins, J.K.3
Fergus, S.4
-
17
-
-
0030960010
-
Expression of Fas ligand in liver metastases of human colonic adenocarcinomas
-
Shiraki K, Tsuji N, Shioda T, Isselbacher KJ, Takahashi H. Expression of Fas ligand in liver metastases of human colonic adenocarcinomas. Proc Natl Acad Sci USA 1997;94:6420-5.
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 6420-6425
-
-
Shiraki, K.1
Tsuji, N.2
Shioda, T.3
Isselbacher, K.J.4
Takahashi, H.5
-
19
-
-
0032522848
-
Human adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis
-
Ungefroren H, Voss M, Jansen M, et al. Human adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis. Cancer Res 1998;58:1741-9.
-
(1998)
Cancer Res
, vol.58
, pp. 1741-1749
-
-
Ungefroren, H.1
Voss, M.2
Jansen, M.3
-
21
-
-
0002324979
-
Pathology of nonendocrine pancreatic tumors
-
Go VLW, Dimagno EP, Gardner JD, Lebenthal E, Scheele GA, eds. New York: Raven Press
-
Klöppel G. Pathology of nonendocrine pancreatic tumors. In: Go VLW, Dimagno EP, Gardner JD, Lebenthal E, Scheele GA, eds. The pancreas. 2nd ed. New York: Raven Press, 1993:871-97.
-
(1993)
The Pancreas. 2nd Ed.
, pp. 871-897
-
-
Klöppel, G.1
-
22
-
-
0028238576
-
Oxidative stress induces NFKB DNA binding and inducible NOS mRNA in human epithelial cells
-
Adcock IM, Brown CR, Kwon O, Barnes PJ. Oxidative stress induces NFKB DNA binding and inducible NOS mRNA in human epithelial cells. Biochem Biophys Res Commun 1994;199:1518-23.
-
(1994)
Biochem Biophys Res Commun
, vol.199
, pp. 1518-1523
-
-
Adcock, I.M.1
Brown, C.R.2
Kwon, O.3
Barnes, P.J.4
-
23
-
-
0028209387
-
Variations in immunohistochemical detection of p53 protein overexpression in cervical carcinomas with different antibodies and methods of detection
-
Lambkin HA, Mothersill CM, Kelehan P. Variations in immunohistochemical detection of p53 protein overexpression in cervical carcinomas with different antibodies and methods of detection. J Pathol 1994;172:13-8.
-
(1994)
J Pathol
, vol.172
, pp. 13-18
-
-
Lambkin, H.A.1
Mothersill, C.M.2
Kelehan, P.3
-
24
-
-
0029921032
-
K-ras mutation and p53 protein accumulation in intraductal mucinhypersecreting neoplasms of the pancreas
-
Satoh K, Shimosegawa T, Moriizumi S, Koizumi S, Toyota T. K-ras mutation and p53 protein accumulation in intraductal mucinhypersecreting neoplasms of the pancreas. Pancreas 1996;12: 362-8.
-
(1996)
Pancreas
, vol.12
, pp. 362-368
-
-
Satoh, K.1
Shimosegawa, T.2
Moriizumi, S.3
Koizumi, S.4
Toyota, T.5
-
25
-
-
0029863103
-
Fas/APO-1/CD95 system as a mediator of granulosa cell apoptosis in ovarian follicle atresia
-
Hakuno N, Koji T, Yano T, et al. Fas/APO-1/CD95 system as a mediator of granulosa cell apoptosis in ovarian follicle atresia. Endocrinology 1996;137:1938-48.
-
(1996)
Endocrinology
, vol.137
, pp. 1938-1948
-
-
Hakuno, N.1
Koji, T.2
Yano, T.3
-
26
-
-
0028900748
-
Induction of apoptosis by sphingosine in human leukemic HL-60 cells: A possible endogenous modulator of apoptotic DNA fragmentation occurring during phorbol ester-induced differentiation
-
Ohta H, Sweeney EA, Masamune A, Yatomi Y, Hakomori S, Igarashi Y. Induction of apoptosis by sphingosine in human leukemic HL-60 cells: a possible endogenous modulator of apoptotic DNA fragmentation occurring during phorbol ester-induced differentiation. Cancer Res 1995;55:691-7.
-
(1995)
Cancer Res
, vol.55
, pp. 691-697
-
-
Ohta, H.1
Sweeney, E.A.2
Masamune, A.3
Yatomi, Y.4
Hakomori, S.5
Igarashi, Y.6
-
27
-
-
0030926392
-
Expression of Fas-estrogen receptor fusion protein induces cell death in pancreatic cancer cell lines
-
Kawaguchi Y, Takebayashi H, Kakizuka A, Arii S, Kato M, Imamura M. Expression of Fas-estrogen receptor fusion protein induces cell death in pancreatic cancer cell lines. Cancer Lett 1997; 116:53-9.
-
(1997)
Cancer Lett
, vol.116
, pp. 53-59
-
-
Kawaguchi, Y.1
Takebayashi, H.2
Kakizuka, A.3
Arii, S.4
Kato, M.5
Imamura, M.6
-
28
-
-
0029066512
-
FAP-1: A protein ryrosine phosphatase that associates with Fas
-
Sato T, Irie S, Kitada S, Reed JC. FAP-1: a protein ryrosine phosphatase that associates with Fas. Science 1995;268:411-5.
-
(1995)
Science
, vol.268
, pp. 411-415
-
-
Sato, T.1
Irie, S.2
Kitada, S.3
Reed, J.C.4
-
29
-
-
0027325182
-
An immunohistochemical study of the c-erb B-2 oncogene product in intraductal mucinhypersecreting neoplasms and in ductal cell carcinomas of the pancreas
-
Satoh K, Sasano H, Shimosegawa T, et al. An immunohistochemical study of the c-erb B-2 oncogene product in intraductal mucinhypersecreting neoplasms and in ductal cell carcinomas of the pancreas. Cancer 1993;72:51-6.
-
(1993)
Cancer
, vol.72
, pp. 51-56
-
-
Satoh, K.1
Sasano, H.2
Shimosegawa, T.3
-
30
-
-
0028063340
-
Infrequent stromal expression of gelatinase A and intact basement membrane in intraductal neoplasms of the pancreas
-
Satoh K, Ohtani H, Shimosegawa T, Koizumi M, Sawai T, Toyota T. Infrequent stromal expression of gelatinase A and intact basement membrane in intraductal neoplasms of the pancreas. Gastroenterology 1994;107:1488-95.
-
(1994)
Gastroenterology
, vol.107
, pp. 1488-1495
-
-
Satoh, K.1
Ohtani, H.2
Shimosegawa, T.3
Koizumi, M.4
Sawai, T.5
Toyota, T.6
-
31
-
-
0031052954
-
Expression of CD44 in duct cell carcinomas and in intraductal neoplasms of the pancreas
-
Satoh K, Shimosegawa T, Koizumi M, Toyota T. Expression of CD44 in duct cell carcinomas and in intraductal neoplasms of the pancreas. Anticancer Res 1997;17:215-20.
-
(1997)
Anticancer Res
, vol.17
, pp. 215-220
-
-
Satoh, K.1
Shimosegawa, T.2
Koizumi, M.3
Toyota, T.4
-
32
-
-
0031957710
-
Expression of transforming growth factor β1 (TGFβ1) and its receptors in pancreatic duct cell carcinoma and in chronic pancreatitis
-
Satoh K, Shimosegawa T, Hirota M, Koizumi M, Toyota T. Expression of transforming growth factor β1 (TGFβ1) and its receptors in pancreatic duct cell carcinoma and in chronic pancreatitis. Pancreas 1998;16:468-74.
-
(1998)
Pancreas
, vol.16
, pp. 468-474
-
-
Satoh, K.1
Shimosegawa, T.2
Hirota, M.3
Koizumi, M.4
Toyota, T.5
|